skip to content
Covid-19 virus
COVID-19 Resources

Reliable information about the coronavirus (COVID-19) is available from the World Health Organization (current situation, international travel). Numerous and frequently-updated resource results are available from this WorldCat.org search. OCLC’s WebJunction has pulled together information and resources to assist library staff as they consider how to handle coronavirus issues in their communities.

Image provided by: CDC/ Alissa Eckert, MS; Dan Higgins, MAM
Bringing Low-Cost Options and Competition while Keeping Incentives for New Generics Act of 2019 : report (to accompany H.R. 938) (including cost estimate of the Congressional Budget Office). Preview this item
ClosePreview this item
Checking...

Bringing Low-Cost Options and Competition while Keeping Incentives for New Generics Act of 2019 : report (to accompany H.R. 938) (including cost estimate of the Congressional Budget Office).

Author: United States. Congress. House. Committee on Energy and Commerce,
Publisher: [Washington, D.C.] : [U.S. Government Publishing Office], [2019]
Series: United States.; Congress.; House.; Report
Edition/Format:   Print book : National government publication : EnglishView all editions and formats
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Legislative materials
Additional Physical Format: Online version:
United States. Congress. House. Committee on Energy and Commerce.
Bringing Low-Cost Options and Competition while Keeping Incentives for New Generics Act of 2019
(OCoLC)1107669191
Material Type: Government publication, National government publication
Document Type: Book
All Authors / Contributors: United States. Congress. House. Committee on Energy and Commerce,
OCLC Number: 1101904809
Notes: "May 2, 2019."
Title from caption.
Shipping list no.: 2019-0222-P.
Description: 59 pages ; 24 cm.
Series Title: United States.; Congress.; House.; Report

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


\n\n

Primary Entity<\/h3>\n
<http:\/\/www.worldcat.org\/oclc\/1101904809<\/a>> # Bringing Low-Cost Options and Competition while Keeping Incentives for New Generics Act of 2019 : report (to accompany H.R. 938) (including cost estimate of the Congressional Budget Office).<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Book<\/a>, schema:CreativeWork<\/a> ;\u00A0\u00A0\u00A0\nlibrary:oclcnum<\/a> \"1101904809<\/span>\" ;\u00A0\u00A0\u00A0\nlibrary:placeOfPublication<\/a> <http:\/\/id.loc.gov\/vocabulary\/countries\/dcu<\/a>> ;\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9119207516#Topic\/generic_drugs_standards_united_states<\/a>> ; # Generic drugs--Standards--United States<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9119207516#Topic\/generic_drugs_prices<\/a>> ; # Generic drugs--Prices<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9119207516#Topic\/drugs_united_states_cost_effectiveness<\/a>> ; # Drugs--United States--Cost effectiveness<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9119207516#Topic\/pharmaceutical_industry_united_states_quality_control<\/a>> ; # Pharmaceutical industry--United States--Quality control<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/id.loc.gov\/authorities\/classification\/KF32<\/a>> ;\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9119207516#Topic\/drugs_cost_effectiveness<\/a>> ; # Drugs--Cost effectiveness<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9119207516#Topic\/pharmaceutical_industry_quality_control<\/a>> ; # Pharmaceutical industry--Quality control<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9119207516#Topic\/generic_drugs_effectiveness_united_states<\/a>> ; # Generic drugs--Effectiveness--United States<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9119207516#Place\/united_states<\/a>> ; # United States.<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9119207516#Topic\/generic_drugs_standards<\/a>> ; # Generic drugs--Standards<\/span>\n\u00A0\u00A0\u00A0\nschema:author<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9119207516#Organization\/united_states_congress_house_committee_on_energy_and_commerce<\/a>> ; # United States. Congress. House. Committee on Energy and Commerce,<\/span>\n\u00A0\u00A0\u00A0\nschema:bookFormat<\/a> bgn:PrintBook<\/a> ;\u00A0\u00A0\u00A0\nschema:datePublished<\/a> \"2019<\/span>\" ;\u00A0\u00A0\u00A0\nschema:exampleOfWork<\/a> <http:\/\/worldcat.org\/entity\/work\/id\/9119207516<\/a>> ;\u00A0\u00A0\u00A0\nschema:genre<\/a> \"Legislative materials<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\nschema:genre<\/a> \"National government publication<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\nschema:genre<\/a> \"Government publication<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\nschema:inLanguage<\/a> \"en<\/span>\" ;\u00A0\u00A0\u00A0\nschema:isPartOf<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9119207516#Series\/report<\/a>> ; # Report ;<\/span>\n\u00A0\u00A0\u00A0\nschema:isPartOf<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9119207516#Series\/report_116th_congress_1st_session_house_of_representatives<\/a>> ; # Report \/ 116th Congress, 1st session, House of Representatives ;<\/span>\n\u00A0\u00A0\u00A0\nschema:isSimilarTo<\/a> <http:\/\/www.worldcat.org\/oclc\/1107669191<\/a>> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Bringing Low-Cost Options and Competition while Keeping Incentives for New Generics Act of 2019 : report (to accompany H.R. 938) (including cost estimate of the Congressional Budget Office).<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\nschema:productID<\/a> \"1101904809<\/span>\" ;\u00A0\u00A0\u00A0\nwdrs:describedby<\/a> <http:\/\/www.worldcat.org\/title\/-\/oclc\/1101904809<\/a>> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n\n

Related Entities<\/h3>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9119207516#Organization\/united_states_congress_house<\/a>> # United States. Congress. House.<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Organization<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"United States. Congress. House.<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9119207516#Organization\/united_states_congress_house_committee_on_energy_and_commerce<\/a>> # United States. Congress. House. Committee on Energy and Commerce,<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Organization<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"United States. Congress. House. Committee on Energy and Commerce,<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9119207516#Place\/united_states<\/a>> # United States.<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Place<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"United States.<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9119207516#Series\/report<\/a>> # Report ;<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nbgn:PublicationSeries<\/a> ;\u00A0\u00A0\u00A0\nschema:creator<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9119207516#Organization\/united_states_congress_house<\/a>> ; # United States. Congress. House.<\/span>\n\u00A0\u00A0\u00A0\nschema:hasPart<\/a> <http:\/\/www.worldcat.org\/oclc\/1101904809<\/a>> ; # Bringing Low-Cost Options and Competition while Keeping Incentives for New Generics Act of 2019 : report (to accompany H.R. 938) (including cost estimate of the Congressional Budget Office).<\/span>\n\u00A0\u00A0\u00A0\nschema:name<\/a> \"Report ;<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9119207516#Series\/report_116th_congress_1st_session_house_of_representatives<\/a>> # Report \/ 116th Congress, 1st session, House of Representatives ;<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nbgn:PublicationSeries<\/a> ;\u00A0\u00A0\u00A0\nschema:hasPart<\/a> <http:\/\/www.worldcat.org\/oclc\/1101904809<\/a>> ; # Bringing Low-Cost Options and Competition while Keeping Incentives for New Generics Act of 2019 : report (to accompany H.R. 938) (including cost estimate of the Congressional Budget Office).<\/span>\n\u00A0\u00A0\u00A0\nschema:name<\/a> \"Report \/ 116th Congress, 1st session, House of Representatives ;<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9119207516#Topic\/drugs_cost_effectiveness<\/a>> # Drugs--Cost effectiveness<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Drugs--Cost effectiveness<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9119207516#Topic\/drugs_united_states_cost_effectiveness<\/a>> # Drugs--United States--Cost effectiveness<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Drugs--United States--Cost effectiveness<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9119207516#Topic\/generic_drugs_effectiveness_united_states<\/a>> # Generic drugs--Effectiveness--United States<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Generic drugs--Effectiveness--United States<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9119207516#Topic\/generic_drugs_prices<\/a>> # Generic drugs--Prices<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Generic drugs--Prices<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9119207516#Topic\/generic_drugs_standards<\/a>> # Generic drugs--Standards<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Generic drugs--Standards<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9119207516#Topic\/generic_drugs_standards_united_states<\/a>> # Generic drugs--Standards--United States<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Generic drugs--Standards--United States<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9119207516#Topic\/pharmaceutical_industry_quality_control<\/a>> # Pharmaceutical industry--Quality control<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Pharmaceutical industry--Quality control<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9119207516#Topic\/pharmaceutical_industry_united_states_quality_control<\/a>> # Pharmaceutical industry--United States--Quality control<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Pharmaceutical industry--United States--Quality control<\/span>\"@en<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/id.loc.gov\/authorities\/classification\/KF32<\/a>>\u00A0\u00A0\u00A0\u00A0a \nschema:Intangible<\/a> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/id.loc.gov\/vocabulary\/countries\/dcu<\/a>>\u00A0\u00A0\u00A0\u00A0a \nschema:Place<\/a> ;\u00A0\u00A0\u00A0\ndcterms:identifier<\/a> \"dcu<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/www.worldcat.org\/oclc\/1107669191<\/a>>\u00A0\u00A0\u00A0\u00A0a \nschema:CreativeWork<\/a> ;\u00A0\u00A0\u00A0\nrdfs:label<\/a> \"Bringing Low-Cost Options and Competition while Keeping Incentives for New Generics Act of 2019<\/span>\" ;\u00A0\u00A0\u00A0\nschema:description<\/a> \"Online version:<\/span>\" ;\u00A0\u00A0\u00A0\nschema:isSimilarTo<\/a> <http:\/\/www.worldcat.org\/oclc\/1101904809<\/a>> ; # Bringing Low-Cost Options and Competition while Keeping Incentives for New Generics Act of 2019 : report (to accompany H.R. 938) (including cost estimate of the Congressional Budget Office).<\/span>\n\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/www.worldcat.org\/title\/-\/oclc\/1101904809<\/a>>\u00A0\u00A0\u00A0\u00A0a \ngenont:InformationResource<\/a>, genont:ContentTypeGenericResource<\/a> ;\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/www.worldcat.org\/oclc\/1101904809<\/a>> ; # Bringing Low-Cost Options and Competition while Keeping Incentives for New Generics Act of 2019 : report (to accompany H.R. 938) (including cost estimate of the Congressional Budget Office).<\/span>\n\u00A0\u00A0\u00A0\nschema:dateModified<\/a> \"2019-07-08<\/span>\" ;\u00A0\u00A0\u00A0\nvoid:inDataset<\/a> <http:\/\/purl.oclc.org\/dataset\/WorldCat<\/a>> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n\n

Content-negotiable representations<\/p>\n